IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift 
Anthropic Reportedly Taps Wilson Sonsini as It Prepares for a Potential 2026 IPO 
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit 
Netflix’s Bid for Warner Bros Discovery Aims to Cut Streaming Costs and Reshape the Industry 
Magnum Audit Flags Governance Issues at Ben & Jerry’s Foundation Ahead of Spin-Off 
Rio Tinto Raises 2025 Copper Output Outlook as Oyu Tolgoi Expansion Accelerates 
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities 
Visa to Move European Headquarters to London’s Canary Wharf 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp 
Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves 
Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum 
IKEA Launches First New Zealand Store, Marking Expansion Into Its 64th Global Market 
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions 
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature 
Proxy Advisors Urge Vote Against ANZ’s Executive Pay Report Amid Scandal Fallout 
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban 
AUSTIN, Texas, Dec. 01, 2015 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and BioElectronics Corporation (OTC Pink:BIEL), the maker of advanced consumer pain management medical devices, announced today that a new audio interview with the Company, is now available. The interview can be heard at http://smallcapvoice.com/blog/11-25-15-smallcapvoice-interview-with-bioelectronics-corp-biel
Rick Staelin, Chairman of the Board, BioElectronics Corporation (BIEL) called in to SmallCapVoice.com, Inc. to go over his Company’s explosive sales growth and the drivers behind that growth. In BIEL’s last quarter they reported 216% increase in sales over the same quarter a year ago ($499,869 versus $231,174). For the nine months ending September 30 they’re up 248 percent ($1,678,665 versus $677,454).
Rick Staelin stated, “I enjoyed talking about innovative marketing program that that we used to launch ActiPatch into the UK market. This program allowed us to greatly expand our distribution as well as sales, even though we started out with almost no brand awareness and a skeptical consumer base.”
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About BioElectronics Corporation
BioElectronics Corporation is the maker of a leading family of affordable, disposable, drug-free, medical devices. ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; HealFast® Therapy and the Allay® Menstrual Pain Therapy. Please visit www.bielcorp.com for more information.
Paul Knopick 940.262.3584 [email protected] For SmallCapVoice.com Stuart T. Smith 512-267-2430 [email protected]
